Genomcore and DIPCAN Transform Metastatic Cancer Treatment in Spain
Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2,000 participants.

Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2,000 participants.


